Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jul;129(7):840-6.
doi: 10.1001/archophthalmol.2011.143.

Grating visual acuity results in the early treatment for retinopathy of prematurity study

Early Treatment for Retinopathy of Prematurity Cooperative Group; Velma Dobson, Graham E Quinn, C Gail Summers, Robert J Hardy, Betty Tung, William V Good
Collaborators
Randomized Controlled Trial

Grating visual acuity results in the early treatment for retinopathy of prematurity study

Early Treatment for Retinopathy of Prematurity Cooperative Group et al. Arch Ophthalmol. 2011 Jul.

Abstract

Objective: To compare grating (resolution) visual acuity at 6 years of age in eyes that received early treatment (ET) for high-risk prethreshold retinopathy of prematurity (ROP) with that in eyes that underwent conventional management (CM).

Methods: In a randomized clinical trial, infants with bilateral, high-risk prethreshold ROP (n = 317) had one eye undergo ET and the other eye undergo CM, with treatment only if ROP progressed to threshold severity. For asymmetric cases (n = 84), the high-risk prethreshold eye was randomized to ET or CM.

Main outcome measure: Grating visual acuity measured at 6 years of age by masked testers using Teller acuity cards.

Results: Monocular grating acuity results were obtained from 317 of 370 surviving children (85.6%). Analysis of grating acuity results for all study participants with high-risk prethreshold ROP showed no statistically significant overall benefit of ET (18.1% vs 22.8% unfavorable outcomes; P = .08). When the 6-year grating acuity results were analyzed according to a clinical algorithm (high-risk types 1 and 2 prethreshold ROP), a benefit was seen in type 1 eyes (16.4% vs 25.2%; P = .004) undergoing ET, but not in type 2 eyes (21.3% vs 15.9%; P = .29).

Conclusion: Early treatment of eyes with type 1 ROP improves grating acuity outcomes, but ET for eyes with type 2 ROP does not. APPLICATION TO CLINICAL MEDICINE: Type 1 eyes should be treated early; however, based on acuity results at 6 years of age, type 2 eyes should be cautiously monitored for progression to type 1 ROP. Trial Registration clinicaltrials.gov Identifier: NCT00027222.

PubMed Disclaimer

Conflict of interest statement

The authors have no affiliation with or financial interest in the subject matter or materials discussed in the paper (e.g., employment, consultancies, stock ownership, honoraria), with the exception of Velma Dobson, PhD, who has received royalties from the sale of Teller acuity cards.

Figures

Figure 1
Figure 1
Algorithm (flow chart) for randomized infants. *Incomplete data was due to failure to cooperate for monocular testing or failure to have had amblyopia therapy prescribed
Figure 2
Figure 2
Distribution of grating acuity outcomes for randomized eyes by treatment assignment. Normal = ≥ 13 cycles/degree; Below Normal = <13 cycles/degree to ≥ 6.4 cycles/degree; Poor = measurable acuity <6.4 cycles/degree; Blind/Low Vision = can detect only the 2.2-cm-wide stripes on the Low Vision Teller acuity card at any distance and at any location in the visual field, light percepti on only, or no light perception. Visual acuities in the Poor and Blind/Low Vision categories were classified as unfavorable outcomes.
Figure 3
Figure 3
Distribution of grating acuity outcomes for randomized eyes with Type 1(Figure 3A) and Type 2 (Figure 3B) ROP by treatment assignments (early treatment (ET) or conventional management (CM)). Normal = ≥ 13 cycles/degree; Below Normal = <13 cycles/degree to ≥ 6.4 cycles/degree; Poor = measurable acuity <6.4 cycles/degree; Blind/Low Vision = can detect only the 2.2-cm-wide stripes on the Low Vision Teller acuity card at any distance and at any location in the visual field, light perception only, or no light perception. Visual acuities in the Poor and Blind/Low Vision categories were classified as unfavorable outcomes.
Figure 3
Figure 3
Distribution of grating acuity outcomes for randomized eyes with Type 1(Figure 3A) and Type 2 (Figure 3B) ROP by treatment assignments (early treatment (ET) or conventional management (CM)). Normal = ≥ 13 cycles/degree; Below Normal = <13 cycles/degree to ≥ 6.4 cycles/degree; Poor = measurable acuity <6.4 cycles/degree; Blind/Low Vision = can detect only the 2.2-cm-wide stripes on the Low Vision Teller acuity card at any distance and at any location in the visual field, light perception only, or no light perception. Visual acuities in the Poor and Blind/Low Vision categories were classified as unfavorable outcomes.
See this image and copyright information in PMC

References

    1. Hardy RJ, Palmer EA, Dobson V, Summers CG, Phelps DL, Quinn GE, Good WV, Tung B. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol. 2003 Dec;121(12):1697–701. - PubMed
    1. Ferris FL, 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982 Jul;94(1):91–6. - PubMed
    1. The Early Treatment for Retinopathy of Prematurity Cooperative Group. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010 Jun;128(6):663–71. - PMC - PubMed
    1. Teller DY, McDonald MA, Preston K, Sebris SL, Dobson V. Assessment of visual acuity in infants and children: the acuity card procedure. Dev Med Child Neurol. 1986 Dec;28(6):779–89. - PubMed
    1. Dobson V, Quinn GE, Biglan AW, Tung B, Flynn JT, Palmer EA. Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1702–8. - PubMed

Publication types

Associated data